Autumn Glory Partners LLC Has $303,000 Stake in Danaher Co. (NYSE:DHR)

Autumn Glory Partners LLC decreased its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 52.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,320 shares of the conglomerate's stock after selling 1,428 shares during the period. Autumn Glory Partners LLC's holdings in Danaher were worth $303,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Heck Capital Advisors LLC bought a new stake in Danaher during the 4th quarter worth about $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher in the 4th quarter valued at about $31,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher in the 4th quarter valued at about $31,000. Strategic Financial Concepts LLC acquired a new stake in Danaher in the 4th quarter valued at about $31,000. Finally, Pineridge Advisors LLC increased its position in Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after buying an additional 57 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently issued reports on DHR shares. UBS Group cut their target price on shares of Danaher from $309.00 to $305.00 and set a "buy" rating for the company in a research note on Wednesday, October 23rd. Guggenheim initiated coverage on Danaher in a research note on Thursday, December 19th. They issued a "buy" rating and a $275.00 price target for the company. Royal Bank of Canada reiterated an "outperform" rating and set a $277.00 price objective (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Citigroup cut their price objective on shares of Danaher from $285.00 to $265.00 and set a "buy" rating for the company in a report on Thursday, January 30th. Finally, Wolfe Research upgraded Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price target for the company in a research note on Thursday, October 31st. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $278.00.

Danaher Trading Up 0.3 %

Danaher stock traded up $0.70 during trading hours on Wednesday, hitting $205.23. The stock had a trading volume of 4,572,680 shares, compared to its average volume of 4,519,168. The stock has a market cap of $148.24 billion, a price-to-earnings ratio of 38.87, a P/E/G ratio of 2.63 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The business's 50 day simple moving average is $228.34 and its 200-day simple moving average is $248.10. Danaher Co. has a one year low of $196.80 and a one year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts' consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the business earned $2.09 earnings per share. On average, equities analysts predict that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.53%. Danaher's payout ratio is 20.45%.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 10.90% of the stock is owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.